Pharmaceutical News

RSS

Atorvastatin drug plus zoledronic acid may help treat toxoplasmosis

Researchers at the University of Georgia have discovered that a combination of two commonly prescribed drugs used to treat high cholesterol and osteoporosis may serve as the foundation of a new treatment for toxoplasmosis, a parasitic infection caused by the protozoan Toxoplasma gondii. They published their findings recently in PLOS Pathogens.

18 Oct 2013

Jain Foundation Steps Up Efforts To Find Cure For Muscular Dystrophy

...

17 Oct 2013

High long-chain omega-3 polyunsaturated fatty acid content may lower risk of brain abnormalities

According to a new study, high long-chain omega-3 polyunsaturated fatty acid content in blood may lower the risk of small brain infarcts and other brain abnormalities in the elderly.

17 Oct 2013

Use of antibiotics to treat catheter-associated bacteriuria infection show no change in mortality rates

With 30 million indwelling bladder catheters placed annually nationwide, patients face an increased risk of developing catheter-associated bacteriuria (bacteria in the urine). Many patients with indwelling urinary catheters acquire bacteria in the urinary tract while they are catheterized.

17 Oct 2013

Using mobile device to check drug info prevents adverse events, say nursing home doctors

Nearly nine out of 10 nursing home physicians said that using their mobile devices to look up prescription drug information prevented at least one adverse drug event in the previous month, according to a University of Pittsburgh School of Medicine Department of Biomedical Informatics study published last week in the Journal of the American Medical Directors Association.

17 Oct 2013

Nintedanib drug to treat NSCLC is submitted for approval from European Medicines Agency

Boehringer Ingelheim announced the submission of a Marketing Authorisation Application to the European Medicines Agency for the approval of its oral triple angiokinase inhibitor nintedanib, in combination with docetaxel, for the treatment of patients with locally advanced, metastatic or recurrent non-small cell lung cancer (NSCLC) of adenocarcinoma tumour histology after first line chemotherapy.

17 Oct 2013

Researchers find novel drug target for anaplastic thyroid carcinomas

Anaplastic thyroid carcinomas are aggressive tumors that do not respond to traditional radio- or chemotherapeutic agents, and there currently is no cure or effective treatment available. Median survival from diagnosis is 5 months, and although ATC accounts for only 1.7% of all thyroid cancers in the U.S., it is responsible for a large proportion of thyroid cancer-related deaths.

17 Oct 2013

Certain blood pressure medications may reduce risk of dementia due to Alzheimer's disease

A Johns Hopkins-led analysis of data previously gathered on more than 3,000 elderly Americans strongly suggests that taking certain blood pressure medications to control blood pressure may reduce the risk of dementia due to Alzheimer's disease.

17 Oct 2013

Jain Foundation Steps Up Efforts To Find Cure For Muscular Dystrophy

...

16 Oct 2013

Pieris Inks Co-Development Deal With Zydus For Protein Drugs

...

16 Oct 2013

Astrazeneca To Use Wyss Institute’s Organs-On-Chips

AstraZeneca has taken a small step in reducing the need for traditional animal testing by signing on to evaluate Organs-on-Chips from the Wyss Institute for Biologically Inspired Engineering at Harvard.

16 Oct 2013

Ticagrelor drug may reduce risk of dying following heart attack

Scientists from the University of Sheffield have discovered ground breaking clues as to how the pioneering heart drug ticagrelor might reduce the risk of dying following a heart attack, in comparison to previous standard treatments.

16 Oct 2013

Pieris, Zydus Cadila partner to develop and commercialize Anticalin-based protein therapeutics

Zydus Cadila, an innovative global pharmaceutical company that discovers, develops, manufactures and markets a broad range of healthcare products, and Pieris AG, a next generation therapeutic protein R&D company, have entered into an alliance for development and commercialization of multiple novel Anticalin-based protein therapeutics, both companies announced today.

16 Oct 2013

Pregnant women exposed to metoclopramide experience no increased risk of congenital malformations

In an analysis that included more than 40,000 women exposed to the nausea medication metoclopramide in pregnancy, use of this drug was not associated with significantly increased risk of major congenital malformations overall, spontaneous abortion, and stillbirth, according to a study in the October 16 issue of JAMA.

16 Oct 2013

Janssen seeks European marketing approval for combination of once-daily darunavir with cobicistat

Janssen-Cilag International NV, today announced it has submitted a Marketing Authorisation Application to the European Medicines Agency seeking approval for a once-daily single tablet fixed-dose antiretroviral combination product containing darunavir, a protease inhibitor developed by Janssen, with cobicistat, a pharmacokinetic enhancer or boosting agent, developed by Gilead Sciences, Inc. for use in combination with other human immunodeficiency virus medicines.

15 Oct 2013

Study explores why girls in minority groups, low-income families don't get HPV vaccine

A new study explores why girls in minority groups and low-income families, who are most at risk for cervical cancer, may not be getting the human papillomavirus or HPV vaccine.

15 Oct 2013

Marketing and technical support cooperation for aqueous acrylic enteric system, Acryl-EZE®, launched by Colorcon and Evonik Industries

Colorcon Inc. and Evonik Industries AG have announced the signing of a cooperation agreement for the marketing and technical support of Acryl-EZE®, aqueous acrylic enteric system.

15 Oct 2013

Pharmaceutical News

Atorvastatin drug plus zoledronic acid may help treat toxoplasmosis

Jain Foundation Steps Up Efforts To Find Cure For Muscular Dystrophy

High long-chain omega-3 polyunsaturated fatty acid content may lower risk of brain abnormalities

Use of antibiotics to treat catheter-associated bacteriuria infection show no change in mortality rates

Using mobile device to check drug info prevents adverse events, say nursing home doctors

Nintedanib drug to treat NSCLC is submitted for approval from European Medicines Agency

Researchers find novel drug target for anaplastic thyroid carcinomas

Certain blood pressure medications may reduce risk of dementia due to Alzheimer's disease

Jain Foundation Steps Up Efforts To Find Cure For Muscular Dystrophy

Pieris Inks Co-Development Deal With Zydus For Protein Drugs

Astrazeneca To Use Wyss Institute’s Organs-On-Chips

Ticagrelor drug may reduce risk of dying following heart attack

Pieris, Zydus Cadila partner to develop and commercialize Anticalin-based protein therapeutics

Pregnant women exposed to metoclopramide experience no increased risk of congenital malformations

Janssen seeks European marketing approval for combination of once-daily darunavir with cobicistat

Study explores why girls in minority groups, low-income families don't get HPV vaccine

Marketing and technical support cooperation for aqueous acrylic enteric system, Acryl-EZE®, launched by Colorcon and Evonik Industries

Researchers to present latest findings in emergency medicine research at ACEP13-Scientific Assembly

Measles-containing vaccines administered at 12-5 months of age associated with reduced risk of fever, seizures

Scientists identify dangerous amount of methamphetamine analog in workout supplement Craze

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Latest News